|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61P 37/02 | |||
| C07K 14/705 | |||
| A01K 67/027 | |||
| A61K 39/00 |
| (11) | Number of the document | 2558498 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11730118.4 |
| Date of filing the European patent application | 2011-04-13 | |
| (97) | Date of publication of the European application | 2013-02-20 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/032355 |
| Date | 2011-04-13 |
| (87) | Number | WO 2011/130434 |
| Date | 2011-10-20 |
| (30) | Number | Date | Country code |
| 471459 P | 2011-04-04 | US | |
| 323720 P | 2010-04-13 | US |
| (72) |
KELER, Tibor, US
MARSH, Henry, C., US
HE, Lizhen, US
VITALE, Laura, A., US
THOMAS, Lawrence, J., US
|
| (73) |
Celldex Therapeutics, Inc.,
119 Fourth Avenue, Needham, MA 02494-2725,
US
|
| (54) | ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF |
| ANTIBODIES THAT BIND HUMAN CD27 AND USES THEREOF |